Nearly all patients who underwent stem cell treatment for amyotrophic lateral sclerosis developed by Brain- Storm Cell Therapeutics Inc. and tested in a Phase 2a clinical trial at the Hadassah University Medical Center in Jerusalem's Ein Kerem "showed clinical benefit," according to the Petah Tikva- and New York-based company. The firm said Monday the trial was carried out by senior Hadassah neurologist and ALS expert Prof.
http://ift.tt/1rYKrd6
http://ift.tt/1rYKrd6
No comments:
Post a Comment